Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomized, open-label, parallel-group, phase 3 trial
The best option depends on your health history, weight loss goals, and provider recommendations
Before making any changes to where you buy your medication or how you take it, be sure to check in with your doctor
Switched to a fattier spot and its way better." - u/MuscleMistake Most users say the pain improves over time as they become more familiar with the process - and that experimenting with injection sites and techniques can make a big difference
SURMOUNT-5 found that tirzepatide produced 20.2% mean weight loss versus 13.7% with semaglutide over 72 weeks in adults with obesity without diabetes a statistically significant 6.5 percentage point difference [10]
US$ 26.02
US$ 27.83
US$ 28.74
